Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise

J Pediatr. 2004 Dec;145(6):731-6. doi: 10.1016/j.jpeds.2004.08.004.

Abstract

Objectives: To assess subclinical inflammation, fasting insulin, and endothelial function before and after exercise in overweight children and adolescents.

Study design: Twenty-five children (body mass index [BMI] >85th percentile) were assessed for brachial artery flow-mediated dilation (FMD), nitroglycerin-induced dilation, C-reactive protein (CRP), lipids, glucose, insulin, oral glucose tolerance, body composition, aerobic fitness (peak oxygen uptake [VO 2 peak]), and blood pressure. Twenty of these persons were equally and randomly assigned to either 8 weeks of stationary cycling or to a non-exercising control group.

Results: A baseline correlation was found between CRP and fasting insulin (r = 0.62; P < .001), which remained significant after adjusting for baseline variables (r = 0.53; P < .05). After 8 weeks, significant improvements were observed in the exercise group compared with the control group for VO 2 peak (exercise group = 21.8 +/- 2.1 to 23.2 +/- 1.5 mL/kg/minute vs control group = 23.4 +/- 1.6 to 20.9 +/- 2.2 mL/kg/minute; P < .05), high-density lipoprotein (HDL) cholesterol (exercise group = 1.02 +/- 0.03 to 1.10 +/- 0.04 mmol/L vs control group = 1.08 +/- 0.07 to 0.99 +/- 0.09 mmol/L; P < .05), and FMD area under the curve (AUC) (exercise group = 746 +/- 66 to 919 +/- 94 %*sec vs control group = 731 +/- 102 to 515 +/- 73 %*sec; P < .05).

Conclusions: In overweight children and adolescents, CRP is independently associated with fasting insulin. Eight weeks of aerobic exercise improves fitness, HDL cholesterol, and endothelial function in this group.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Blood Glucose
  • Body Mass Index
  • C-Reactive Protein / metabolism
  • Child
  • Cholesterol / blood
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology*
  • Exercise*
  • Female
  • Humans
  • Inflammation / complications
  • Inflammation / metabolism*
  • Insulin / blood*
  • Insulin Resistance
  • Male
  • Metabolic Syndrome / metabolism*
  • Metabolic Syndrome / therapy
  • Nitroglycerin / pharmacology
  • Obesity* / complications
  • Obesity* / metabolism
  • Obesity* / therapy
  • Oxygen Consumption
  • Vasodilation / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Blood Glucose
  • Insulin
  • Vasodilator Agents
  • C-Reactive Protein
  • Cholesterol
  • Nitroglycerin